
TrippelTarg - Triple Targeting of Biodegradable Nanoparticles for Treatment of Cancer
SINTEF want to further develop a targeted treatment strategy that has shown promising effects in animals with patient-derived tumors. The strategy is based on the use of nanoparticles developed by SINTEF containing a cytostatic drug.